Consensus Curriculum for Fellowship Training in Multiple Sclerosis and Neuroimmunology.

Journal

Neurology. Clinical practice
ISSN: 2163-0402
Titre abrégé: Neurol Clin Pract
Pays: United States
ID NLM: 101577149

Informations de publication

Date de publication:
Aug 2021
Historique:
received: 17 07 2020
accepted: 16 11 2020
entrez: 6 9 2021
pubmed: 7 9 2021
medline: 7 9 2021
Statut: ppublish

Résumé

Management of multiple sclerosis and neuroimmunologic disorders has become increasingly complex because of the expanding number of recognized neuroimmune disorders, increased number of therapeutic options, and multidisciplinary care management needs of people with multiple sclerosis and neuroimmunologic disorders. More subspecialists are needed to optimize care of these patients, and many fellowship programs have been created or expanded to increase the subspecialty workforce. Consequently, defining the scope and standardizing fellowship training is essential to ensure that trainees receive high-quality training. A workgroup was created to develop a consensus fellowship curriculum to serve as a resource for all current and future training programs. This curriculum may also serve as a basis for future accreditation efforts.

Identifiants

DOI: 10.1212/CPJ.0000000000001040 PMID: 34484933 PMC: PMC8382436
pubmed: 34484933
doi: 10.1212/CPJ.0000000000001040
pii: NEURCLINPRACT2020061648
pmc: PMC8382436
doi:

Types de publication

Journal Article

Langues

eng

Pagination

352-357

Subventions

Organisme : NINDS NIH HHS
ID : K23 NS107624
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States

Informations de copyright

Copyright © 2021 American Academy of Neurology.

Références

Mult Scler Int. 2014;2014:624790
pubmed: 24949203
Int J MS Care. 2014 Spring;16(1):26-38
pubmed: 24688352
Nat Rev Neurol. 2017 Sep;13(9):567-572
pubmed: 28799551
Mult Scler Relat Disord. 2020 Sep;44:102296
pubmed: 32585616
Noro Psikiyatr Ars. 2017 Jun 20;56(4):269-272
pubmed: 31903035
Neurology. 2020 Mar 17;94(11):495-500
pubmed: 32107321
Neurology. 2019 Mar 5;92(10):e1029-e1040
pubmed: 30770430
Int J MS Care. 2018 Jan-Feb;20(1):35-43
pubmed: 29507541

Auteurs

Le H Hua (LH)

Cleveland Clinic Lou Ruvo Center for Brain Health (LHH), Las Vegas, NV; Department of Neurology (AZO), Medical College of Wisconsin, Milwaukee; Keck School of Medicine at University of Southern California (LA), Los Angeles; Cleveland Clinic Mellen Center for Multiple Sclerosis Treatment and Research (JAC), OH; National Multiple Sclerosis Society (KC), New York, NY; Department of Neurology (JD), Stanford University School of Medicine, CA; Department of Neurology (JMG), University of California, San Francisco; Virginia Commonwealth University (MDG), Richmond; Children's Hospital of Philadelphia (SH), University of Pennsylvania Perelman School of Medicine; Piedmont Healthcare (DJ), Mooresville, NC; Corinne Goldsmith Dickinson Center for Multiple Sclerosis (SK), Icahn School of Medicine at Mount Sinai, New York, NY; Johns Hopkins School of Medicine (SDN), Baltimore, MD; Duke University School of Medicine (SS), Durham, NC; Department of Neurology (NLS), Cedars-Sinai Medical Center, Los Angeles, CA; Oregon Health and Science University (VY), Portland VA Medical Center, Portland; Veterans Affairs Multiple Sclerosis Centers of Excellence (VY); and Yale School of Medicine (EEL), Yale University, New Haven, CT.
ORCID: 0000-0002-0535-3978

Ahmed Z Obeidat (AZ)

Cleveland Clinic Lou Ruvo Center for Brain Health (LHH), Las Vegas, NV; Department of Neurology (AZO), Medical College of Wisconsin, Milwaukee; Keck School of Medicine at University of Southern California (LA), Los Angeles; Cleveland Clinic Mellen Center for Multiple Sclerosis Treatment and Research (JAC), OH; National Multiple Sclerosis Society (KC), New York, NY; Department of Neurology (JD), Stanford University School of Medicine, CA; Department of Neurology (JMG), University of California, San Francisco; Virginia Commonwealth University (MDG), Richmond; Children's Hospital of Philadelphia (SH), University of Pennsylvania Perelman School of Medicine; Piedmont Healthcare (DJ), Mooresville, NC; Corinne Goldsmith Dickinson Center for Multiple Sclerosis (SK), Icahn School of Medicine at Mount Sinai, New York, NY; Johns Hopkins School of Medicine (SDN), Baltimore, MD; Duke University School of Medicine (SS), Durham, NC; Department of Neurology (NLS), Cedars-Sinai Medical Center, Los Angeles, CA; Oregon Health and Science University (VY), Portland VA Medical Center, Portland; Veterans Affairs Multiple Sclerosis Centers of Excellence (VY); and Yale School of Medicine (EEL), Yale University, New Haven, CT.

Lilyana Amezcua (L)

Cleveland Clinic Lou Ruvo Center for Brain Health (LHH), Las Vegas, NV; Department of Neurology (AZO), Medical College of Wisconsin, Milwaukee; Keck School of Medicine at University of Southern California (LA), Los Angeles; Cleveland Clinic Mellen Center for Multiple Sclerosis Treatment and Research (JAC), OH; National Multiple Sclerosis Society (KC), New York, NY; Department of Neurology (JD), Stanford University School of Medicine, CA; Department of Neurology (JMG), University of California, San Francisco; Virginia Commonwealth University (MDG), Richmond; Children's Hospital of Philadelphia (SH), University of Pennsylvania Perelman School of Medicine; Piedmont Healthcare (DJ), Mooresville, NC; Corinne Goldsmith Dickinson Center for Multiple Sclerosis (SK), Icahn School of Medicine at Mount Sinai, New York, NY; Johns Hopkins School of Medicine (SDN), Baltimore, MD; Duke University School of Medicine (SS), Durham, NC; Department of Neurology (NLS), Cedars-Sinai Medical Center, Los Angeles, CA; Oregon Health and Science University (VY), Portland VA Medical Center, Portland; Veterans Affairs Multiple Sclerosis Centers of Excellence (VY); and Yale School of Medicine (EEL), Yale University, New Haven, CT.

Jeffrey A Cohen (JA)

Cleveland Clinic Lou Ruvo Center for Brain Health (LHH), Las Vegas, NV; Department of Neurology (AZO), Medical College of Wisconsin, Milwaukee; Keck School of Medicine at University of Southern California (LA), Los Angeles; Cleveland Clinic Mellen Center for Multiple Sclerosis Treatment and Research (JAC), OH; National Multiple Sclerosis Society (KC), New York, NY; Department of Neurology (JD), Stanford University School of Medicine, CA; Department of Neurology (JMG), University of California, San Francisco; Virginia Commonwealth University (MDG), Richmond; Children's Hospital of Philadelphia (SH), University of Pennsylvania Perelman School of Medicine; Piedmont Healthcare (DJ), Mooresville, NC; Corinne Goldsmith Dickinson Center for Multiple Sclerosis (SK), Icahn School of Medicine at Mount Sinai, New York, NY; Johns Hopkins School of Medicine (SDN), Baltimore, MD; Duke University School of Medicine (SS), Durham, NC; Department of Neurology (NLS), Cedars-Sinai Medical Center, Los Angeles, CA; Oregon Health and Science University (VY), Portland VA Medical Center, Portland; Veterans Affairs Multiple Sclerosis Centers of Excellence (VY); and Yale School of Medicine (EEL), Yale University, New Haven, CT.

Kathleen Costello (K)

Cleveland Clinic Lou Ruvo Center for Brain Health (LHH), Las Vegas, NV; Department of Neurology (AZO), Medical College of Wisconsin, Milwaukee; Keck School of Medicine at University of Southern California (LA), Los Angeles; Cleveland Clinic Mellen Center for Multiple Sclerosis Treatment and Research (JAC), OH; National Multiple Sclerosis Society (KC), New York, NY; Department of Neurology (JD), Stanford University School of Medicine, CA; Department of Neurology (JMG), University of California, San Francisco; Virginia Commonwealth University (MDG), Richmond; Children's Hospital of Philadelphia (SH), University of Pennsylvania Perelman School of Medicine; Piedmont Healthcare (DJ), Mooresville, NC; Corinne Goldsmith Dickinson Center for Multiple Sclerosis (SK), Icahn School of Medicine at Mount Sinai, New York, NY; Johns Hopkins School of Medicine (SDN), Baltimore, MD; Duke University School of Medicine (SS), Durham, NC; Department of Neurology (NLS), Cedars-Sinai Medical Center, Los Angeles, CA; Oregon Health and Science University (VY), Portland VA Medical Center, Portland; Veterans Affairs Multiple Sclerosis Centers of Excellence (VY); and Yale School of Medicine (EEL), Yale University, New Haven, CT.

Jeffrey Dunn (J)

Cleveland Clinic Lou Ruvo Center for Brain Health (LHH), Las Vegas, NV; Department of Neurology (AZO), Medical College of Wisconsin, Milwaukee; Keck School of Medicine at University of Southern California (LA), Los Angeles; Cleveland Clinic Mellen Center for Multiple Sclerosis Treatment and Research (JAC), OH; National Multiple Sclerosis Society (KC), New York, NY; Department of Neurology (JD), Stanford University School of Medicine, CA; Department of Neurology (JMG), University of California, San Francisco; Virginia Commonwealth University (MDG), Richmond; Children's Hospital of Philadelphia (SH), University of Pennsylvania Perelman School of Medicine; Piedmont Healthcare (DJ), Mooresville, NC; Corinne Goldsmith Dickinson Center for Multiple Sclerosis (SK), Icahn School of Medicine at Mount Sinai, New York, NY; Johns Hopkins School of Medicine (SDN), Baltimore, MD; Duke University School of Medicine (SS), Durham, NC; Department of Neurology (NLS), Cedars-Sinai Medical Center, Los Angeles, CA; Oregon Health and Science University (VY), Portland VA Medical Center, Portland; Veterans Affairs Multiple Sclerosis Centers of Excellence (VY); and Yale School of Medicine (EEL), Yale University, New Haven, CT.

Jeffrey M Gelfand (JM)

Cleveland Clinic Lou Ruvo Center for Brain Health (LHH), Las Vegas, NV; Department of Neurology (AZO), Medical College of Wisconsin, Milwaukee; Keck School of Medicine at University of Southern California (LA), Los Angeles; Cleveland Clinic Mellen Center for Multiple Sclerosis Treatment and Research (JAC), OH; National Multiple Sclerosis Society (KC), New York, NY; Department of Neurology (JD), Stanford University School of Medicine, CA; Department of Neurology (JMG), University of California, San Francisco; Virginia Commonwealth University (MDG), Richmond; Children's Hospital of Philadelphia (SH), University of Pennsylvania Perelman School of Medicine; Piedmont Healthcare (DJ), Mooresville, NC; Corinne Goldsmith Dickinson Center for Multiple Sclerosis (SK), Icahn School of Medicine at Mount Sinai, New York, NY; Johns Hopkins School of Medicine (SDN), Baltimore, MD; Duke University School of Medicine (SS), Durham, NC; Department of Neurology (NLS), Cedars-Sinai Medical Center, Los Angeles, CA; Oregon Health and Science University (VY), Portland VA Medical Center, Portland; Veterans Affairs Multiple Sclerosis Centers of Excellence (VY); and Yale School of Medicine (EEL), Yale University, New Haven, CT.

Myla D Goldman (MD)

Cleveland Clinic Lou Ruvo Center for Brain Health (LHH), Las Vegas, NV; Department of Neurology (AZO), Medical College of Wisconsin, Milwaukee; Keck School of Medicine at University of Southern California (LA), Los Angeles; Cleveland Clinic Mellen Center for Multiple Sclerosis Treatment and Research (JAC), OH; National Multiple Sclerosis Society (KC), New York, NY; Department of Neurology (JD), Stanford University School of Medicine, CA; Department of Neurology (JMG), University of California, San Francisco; Virginia Commonwealth University (MDG), Richmond; Children's Hospital of Philadelphia (SH), University of Pennsylvania Perelman School of Medicine; Piedmont Healthcare (DJ), Mooresville, NC; Corinne Goldsmith Dickinson Center for Multiple Sclerosis (SK), Icahn School of Medicine at Mount Sinai, New York, NY; Johns Hopkins School of Medicine (SDN), Baltimore, MD; Duke University School of Medicine (SS), Durham, NC; Department of Neurology (NLS), Cedars-Sinai Medical Center, Los Angeles, CA; Oregon Health and Science University (VY), Portland VA Medical Center, Portland; Veterans Affairs Multiple Sclerosis Centers of Excellence (VY); and Yale School of Medicine (EEL), Yale University, New Haven, CT.
ORCID: 0000-0002-5675-945X

Sarah Hopkins (S)

Cleveland Clinic Lou Ruvo Center for Brain Health (LHH), Las Vegas, NV; Department of Neurology (AZO), Medical College of Wisconsin, Milwaukee; Keck School of Medicine at University of Southern California (LA), Los Angeles; Cleveland Clinic Mellen Center for Multiple Sclerosis Treatment and Research (JAC), OH; National Multiple Sclerosis Society (KC), New York, NY; Department of Neurology (JD), Stanford University School of Medicine, CA; Department of Neurology (JMG), University of California, San Francisco; Virginia Commonwealth University (MDG), Richmond; Children's Hospital of Philadelphia (SH), University of Pennsylvania Perelman School of Medicine; Piedmont Healthcare (DJ), Mooresville, NC; Corinne Goldsmith Dickinson Center for Multiple Sclerosis (SK), Icahn School of Medicine at Mount Sinai, New York, NY; Johns Hopkins School of Medicine (SDN), Baltimore, MD; Duke University School of Medicine (SS), Durham, NC; Department of Neurology (NLS), Cedars-Sinai Medical Center, Los Angeles, CA; Oregon Health and Science University (VY), Portland VA Medical Center, Portland; Veterans Affairs Multiple Sclerosis Centers of Excellence (VY); and Yale School of Medicine (EEL), Yale University, New Haven, CT.

Douglas Jeffery (D)

Cleveland Clinic Lou Ruvo Center for Brain Health (LHH), Las Vegas, NV; Department of Neurology (AZO), Medical College of Wisconsin, Milwaukee; Keck School of Medicine at University of Southern California (LA), Los Angeles; Cleveland Clinic Mellen Center for Multiple Sclerosis Treatment and Research (JAC), OH; National Multiple Sclerosis Society (KC), New York, NY; Department of Neurology (JD), Stanford University School of Medicine, CA; Department of Neurology (JMG), University of California, San Francisco; Virginia Commonwealth University (MDG), Richmond; Children's Hospital of Philadelphia (SH), University of Pennsylvania Perelman School of Medicine; Piedmont Healthcare (DJ), Mooresville, NC; Corinne Goldsmith Dickinson Center for Multiple Sclerosis (SK), Icahn School of Medicine at Mount Sinai, New York, NY; Johns Hopkins School of Medicine (SDN), Baltimore, MD; Duke University School of Medicine (SS), Durham, NC; Department of Neurology (NLS), Cedars-Sinai Medical Center, Los Angeles, CA; Oregon Health and Science University (VY), Portland VA Medical Center, Portland; Veterans Affairs Multiple Sclerosis Centers of Excellence (VY); and Yale School of Medicine (EEL), Yale University, New Haven, CT.

Stephen Krieger (S)

Cleveland Clinic Lou Ruvo Center for Brain Health (LHH), Las Vegas, NV; Department of Neurology (AZO), Medical College of Wisconsin, Milwaukee; Keck School of Medicine at University of Southern California (LA), Los Angeles; Cleveland Clinic Mellen Center for Multiple Sclerosis Treatment and Research (JAC), OH; National Multiple Sclerosis Society (KC), New York, NY; Department of Neurology (JD), Stanford University School of Medicine, CA; Department of Neurology (JMG), University of California, San Francisco; Virginia Commonwealth University (MDG), Richmond; Children's Hospital of Philadelphia (SH), University of Pennsylvania Perelman School of Medicine; Piedmont Healthcare (DJ), Mooresville, NC; Corinne Goldsmith Dickinson Center for Multiple Sclerosis (SK), Icahn School of Medicine at Mount Sinai, New York, NY; Johns Hopkins School of Medicine (SDN), Baltimore, MD; Duke University School of Medicine (SS), Durham, NC; Department of Neurology (NLS), Cedars-Sinai Medical Center, Los Angeles, CA; Oregon Health and Science University (VY), Portland VA Medical Center, Portland; Veterans Affairs Multiple Sclerosis Centers of Excellence (VY); and Yale School of Medicine (EEL), Yale University, New Haven, CT.

Scott D Newsome (SD)

Cleveland Clinic Lou Ruvo Center for Brain Health (LHH), Las Vegas, NV; Department of Neurology (AZO), Medical College of Wisconsin, Milwaukee; Keck School of Medicine at University of Southern California (LA), Los Angeles; Cleveland Clinic Mellen Center for Multiple Sclerosis Treatment and Research (JAC), OH; National Multiple Sclerosis Society (KC), New York, NY; Department of Neurology (JD), Stanford University School of Medicine, CA; Department of Neurology (JMG), University of California, San Francisco; Virginia Commonwealth University (MDG), Richmond; Children's Hospital of Philadelphia (SH), University of Pennsylvania Perelman School of Medicine; Piedmont Healthcare (DJ), Mooresville, NC; Corinne Goldsmith Dickinson Center for Multiple Sclerosis (SK), Icahn School of Medicine at Mount Sinai, New York, NY; Johns Hopkins School of Medicine (SDN), Baltimore, MD; Duke University School of Medicine (SS), Durham, NC; Department of Neurology (NLS), Cedars-Sinai Medical Center, Los Angeles, CA; Oregon Health and Science University (VY), Portland VA Medical Center, Portland; Veterans Affairs Multiple Sclerosis Centers of Excellence (VY); and Yale School of Medicine (EEL), Yale University, New Haven, CT.

Suma Shah (S)

Cleveland Clinic Lou Ruvo Center for Brain Health (LHH), Las Vegas, NV; Department of Neurology (AZO), Medical College of Wisconsin, Milwaukee; Keck School of Medicine at University of Southern California (LA), Los Angeles; Cleveland Clinic Mellen Center for Multiple Sclerosis Treatment and Research (JAC), OH; National Multiple Sclerosis Society (KC), New York, NY; Department of Neurology (JD), Stanford University School of Medicine, CA; Department of Neurology (JMG), University of California, San Francisco; Virginia Commonwealth University (MDG), Richmond; Children's Hospital of Philadelphia (SH), University of Pennsylvania Perelman School of Medicine; Piedmont Healthcare (DJ), Mooresville, NC; Corinne Goldsmith Dickinson Center for Multiple Sclerosis (SK), Icahn School of Medicine at Mount Sinai, New York, NY; Johns Hopkins School of Medicine (SDN), Baltimore, MD; Duke University School of Medicine (SS), Durham, NC; Department of Neurology (NLS), Cedars-Sinai Medical Center, Los Angeles, CA; Oregon Health and Science University (VY), Portland VA Medical Center, Portland; Veterans Affairs Multiple Sclerosis Centers of Excellence (VY); and Yale School of Medicine (EEL), Yale University, New Haven, CT.

Nancy L Sicotte (NL)

Cleveland Clinic Lou Ruvo Center for Brain Health (LHH), Las Vegas, NV; Department of Neurology (AZO), Medical College of Wisconsin, Milwaukee; Keck School of Medicine at University of Southern California (LA), Los Angeles; Cleveland Clinic Mellen Center for Multiple Sclerosis Treatment and Research (JAC), OH; National Multiple Sclerosis Society (KC), New York, NY; Department of Neurology (JD), Stanford University School of Medicine, CA; Department of Neurology (JMG), University of California, San Francisco; Virginia Commonwealth University (MDG), Richmond; Children's Hospital of Philadelphia (SH), University of Pennsylvania Perelman School of Medicine; Piedmont Healthcare (DJ), Mooresville, NC; Corinne Goldsmith Dickinson Center for Multiple Sclerosis (SK), Icahn School of Medicine at Mount Sinai, New York, NY; Johns Hopkins School of Medicine (SDN), Baltimore, MD; Duke University School of Medicine (SS), Durham, NC; Department of Neurology (NLS), Cedars-Sinai Medical Center, Los Angeles, CA; Oregon Health and Science University (VY), Portland VA Medical Center, Portland; Veterans Affairs Multiple Sclerosis Centers of Excellence (VY); and Yale School of Medicine (EEL), Yale University, New Haven, CT.

Vijayshree Yadav (V)

Cleveland Clinic Lou Ruvo Center for Brain Health (LHH), Las Vegas, NV; Department of Neurology (AZO), Medical College of Wisconsin, Milwaukee; Keck School of Medicine at University of Southern California (LA), Los Angeles; Cleveland Clinic Mellen Center for Multiple Sclerosis Treatment and Research (JAC), OH; National Multiple Sclerosis Society (KC), New York, NY; Department of Neurology (JD), Stanford University School of Medicine, CA; Department of Neurology (JMG), University of California, San Francisco; Virginia Commonwealth University (MDG), Richmond; Children's Hospital of Philadelphia (SH), University of Pennsylvania Perelman School of Medicine; Piedmont Healthcare (DJ), Mooresville, NC; Corinne Goldsmith Dickinson Center for Multiple Sclerosis (SK), Icahn School of Medicine at Mount Sinai, New York, NY; Johns Hopkins School of Medicine (SDN), Baltimore, MD; Duke University School of Medicine (SS), Durham, NC; Department of Neurology (NLS), Cedars-Sinai Medical Center, Los Angeles, CA; Oregon Health and Science University (VY), Portland VA Medical Center, Portland; Veterans Affairs Multiple Sclerosis Centers of Excellence (VY); and Yale School of Medicine (EEL), Yale University, New Haven, CT.

Erin E Longbrake (EE)

Cleveland Clinic Lou Ruvo Center for Brain Health (LHH), Las Vegas, NV; Department of Neurology (AZO), Medical College of Wisconsin, Milwaukee; Keck School of Medicine at University of Southern California (LA), Los Angeles; Cleveland Clinic Mellen Center for Multiple Sclerosis Treatment and Research (JAC), OH; National Multiple Sclerosis Society (KC), New York, NY; Department of Neurology (JD), Stanford University School of Medicine, CA; Department of Neurology (JMG), University of California, San Francisco; Virginia Commonwealth University (MDG), Richmond; Children's Hospital of Philadelphia (SH), University of Pennsylvania Perelman School of Medicine; Piedmont Healthcare (DJ), Mooresville, NC; Corinne Goldsmith Dickinson Center for Multiple Sclerosis (SK), Icahn School of Medicine at Mount Sinai, New York, NY; Johns Hopkins School of Medicine (SDN), Baltimore, MD; Duke University School of Medicine (SS), Durham, NC; Department of Neurology (NLS), Cedars-Sinai Medical Center, Los Angeles, CA; Oregon Health and Science University (VY), Portland VA Medical Center, Portland; Veterans Affairs Multiple Sclerosis Centers of Excellence (VY); and Yale School of Medicine (EEL), Yale University, New Haven, CT.

Classifications MeSH